Endo Licenses Novel Pain Therapy From Grunenthal

Endo Licenses Novel Pain Therapy From Grunenthal

AACHEN, Germany, March 2 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced that it has licensed from Grunenthal the exclusive rights to develop and market the investigational drug…